Vet Clin Path Journal Sat, 25 Sep 2021 17:02:26 +0000 en-US hourly 1 Vet Clin Path Journal 32 32 Neoadjuvant IO response suggesting long-term benefit in HPV – HNSCC Sat, 25 Sep 2021 16:05:16 +0000

Ravindra Uppaluri, MD, PhD, noted during the presentation that ongoing trials are examining the use of neoadjuvant OI in all types of head and neck cancer, as this approach can help induce an immune response. to provide lasting benefit long after surgery and potentially reduce the need to add adjuvant therapies.

For patients with HNSCC in particular, relapse is still a major concern after surgery, so researchers hope that neoadjuvant therapy for these patients would improve outcomes.

Uppaluri, head of the otolaryngology division at Brigham and Women’s Hospital in Boston, Mass., Explained that neoadjuvant inhibition of immune checkpoints would activate the immune response against the primary tumor as well as the lymph nodes. regional. Since patients receiving neoadjuvant therapy have an intact immune system since they have not yet been treated, they would likely be more sensitive to treatment, and the immune system would then be primed for a greater anti-tumor lymphocyte response. T.2 This can be best seen, Uppaluri said, in terms of the pathological tumor response after neoadjuvant therapy, which is an indication of an activated immune response.

Currently, only a limited number of patients with HNSCC achieve a partial molecular response or a pathologic complete response to neoadjuvant OI as monotherapy compared to what has been observed in other types of tumors, such as melanoma. Yet, up to 70% of patients with HNSCC show some degree of pathological response.1

New data suggests that even with any degree of pathologic response, there is still a benefit in patients in terms of delaying relapse. In a meta-analysis of neoadjuvant melanoma trials, any pathologic response resulted in a higher recurrence-free survival rate (SSR). In patients with a pathologic complete response (pCR), the rate of RFS was 100% at 2 years; in those with a close pCR, the rate of RFS was 89%, and it was 61% for those with a pathologic partial response (pPR). With particular immunotherapy treatment, the rate of RFS at 2 years was 96% for any patient with pCR, near-pCR or pPR.3

“We see it now in the head and neck [cancer]”said Uppaluri.

In a study (NCT02641093) presented at the 2021 American Society of Clinical Oncology annual meeting on neoadjuvant pembrolizumab (Keytruda) in patients with HPV-negative, resectable and locally advanced HNSCC, 8% of patients had exhibited a partial molecular response and 38% exhibited a pathological response. At 1 year, the disease-free survival rate was 100% in patients with a pathologic response and 73% in non-responders (RR: 0.23; 95% CI: 0.06-0.81; P = .013). The 2-year overall survival rate was 95% in patients who achieved a partial response and 61% in patients who did not respond (P = .00078).4

The study authors concluded that the pathological response could be a promising surrogate for long-term disease control.

Uppaluri suggested that differential gene expression can be found between patients who respond pathologically and those who do not. In a phase 2 trial (NCT02296684) of neoadjuvant and adjuvant pembrolizumab in patients with resectable, locally advanced, HPV-unrelated HNSCC, researchers examined the immunologic correlates of tumor response to neoadjuvant therapy and found increased expression of immune and inflammatory gene signatures in baseline responders. Compared to patients who did not show a pathological response, responders showed increased baseline expression of the IFNG, CXCL9, CXCL10 and C XC L11 genes (P <0.01; false discovery rate, <.2).5

“In patients who have answers … there is a very strong signature of interferon-γ. It is a well-known signature which …[can] predict pathological responses, ”Uppaluri said.

Going forward, although encouraging data has been observed, Uppaluri noted that many unanswered questions need to be answered and that more research is needed in larger randomized trials. Among these remaining questions, Uppaluri asked what the clinical impact will be for patients and how the appropriate patients who will derive the most benefit can be selected to receive neoadjuvant therapy.

The ongoing KEYNOTE-689 Phase 3 trial (NCT03765918) is one that Uppaluri says will help answer some of these questions. The trial examines the use of neoadjuvant and adjuvant pembrolizumab in patients with locally advanced resectable HNSCC. In the study, patients will be randomized 1: 1 to receive pembrolizumab as a neoadjuvant or no treatment, followed by surgery, then pembrolizumab plus radiotherapy with or without added cisplatin (depending on risk category) or radiotherapy with or without cisplatin alone. The trial is expected to enroll around 300 patients.

1. Uppaluri R. Neoadjuvant immunotherapy before surgery for HPV-negative head and neck cancer. Presented at the 10th American Head & Neck Society International Conference on Head and Neck Cancer; July 22-25, 2021; virtual.
2. Topalian SL, Taube JM, Pardoll DM. Blockade of neoadjuvant checkpoints for cancer immunotherapy. Science. 2020; 367 (6477): eaax0182. doi: 10.1126 / science.aax0182
3. Menzies AM, Amaria RN, Rozeman EA, et al. Pathological response and survival with neoadjuvant therapy in melanoma: a pooled review by the International Neoadjuvant Melanoma Consortium (INMC). Nat Med. 2021; 27 (2): 301-309. doi: 10.1038 / s41591-020-01188-3
4. Wise-Draper TM, Takiar V, Mierzwa ML, et al. Association of pathological response to neoadjuvant pembrolizumab with tumor expression of PD-L1 and high disease-free survival (DFS) in patients with resectable, locally-regionally advanced squamous cell carcinoma of the head and neck (HNSCC) . J Clin Oncol. 2021; 39 (suppl 15): 6006. doi: 10.1200 / JCO.2021.39.15_suppl.6006
5. Uppaluri R, Campbell KM, Egloff AM, et al. Neoadjuvant and adjuvant pembrolizumab in locally advanced resectable head and neck cancer unrelated to human papillomavirus: a multicenter phase II trial. Clin Cancer Res. 2020; 26 (19): 5140-5152. doi: 10.1158 / 1078-0432.CCR-20-1695
Source link

]]> 0
24/7 emergency laboratory to perform 50,000 tests per day at AIIMS Delhi Sat, 25 Sep 2021 15:39:36 +0000

In a major relief for patients who present to AIIMS Delhi, an emergency laboratory has been set up which will be operational for 24 hours to perform regular tests on patients here. This is AIIMS Delhi’s “second smart lab”. The laboratory uses automatic dry chemistry analysis technology.

Officials said the time for taking diagnostic test samples from wards has been increased by three and a half hours. “This new lab is open 24 hours. At any time, patients can come and we will give the report, as soon as possible. It will not take more than two to three hours to submit the test reports,” said Dr Shyam. . Prakash, Additional Professor, Department of Laboratory Medicine, Faculty in charge of the Smart lab.

The lab also helps patients get timely treatment without any delay in test results. “Previously, patients waited a long time outside the testing labs for the report to be released. But now we get the report within two to three hours. Thanks to this, our consultants or clinicians can give immediate feedback, analyze the diagnosis and give them medication immediately, ”said Dr Prakash.

The 24/7 Emergency Laboratory is AIIMS Delhi’s second smart laboratory inaugurated today by Union Minister of Health Mansukh Mandaviya. This laboratory has the capacity to perform over 50,000 tests in a single day. On September 22, AIIMS Delhi prepared a “smart lab” capable of performing more than two lakh of general tests in a single day. The high-tech lab also offers free tests such as the D-Dimer test which costs around Rs 1,000 at private labs.

“If a patient arrives urgently at 12 p.m., the number of investigative parameters available to the physician to assess and treat the patient is comparatively much more limited. hours, we can easily study all the parameters in a few hours with the help of this smart lab, ”said Dr Subrata Sinha, Head of Electronic Department of Laboratory Medicine, AIIMS Delhi. This lab performs 2,500 to 3,000 tests per hour and 50,000 to 60,000 tests per day, Sinha added.

Regarding the accuracy of the tests, Dr Subrata Sinha said: “All of our testing is very accurate, we have an internal quality control and external quality control system where we link to the quality control program. , our staff and physicians find that quality parameters are maintained day to day. ” (ANI)

(This story was not edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Source link

]]> 0
First digital AI pathology approved for prostate cancer Sat, 25 Sep 2021 14:48:41 +0000

Source: Free-Photos / Pixabay

Artificial Intelligence (AI) machine learning is rapidly transforming healthcare by powering new diagnostic tools for clinicians and healthcare professionals. In a landmark move this week, the United States Food and Drug Administration (FDA) cleared the marketing of an AI machine learning software called Paige Prostate, the first approved AI-based software that identifies the prostate cancer to help pathologists.

The FDA De Novo pre-market review process is for new types of low to moderate risk devices. With FDA approval from De Novo, the new device is cleared for sale in accordance with regulatory controls.

“Authorizing this AI-based software may help increase the number of prostate biopsy samples identified with cancerous tissue, which may ultimately save lives,” said Tim Stenzel, MD, Ph. D., director of the Office of In Vitro Diagnostics and Radiological Health at the FDA’s Center for Devices and Radiological Health in a statement.

Prostate cancer is one of the most common cancers in American men, second only to skin cancer. According to the American Cancer Society (ACS), about 1 in 8 men in the United States will be diagnosed with prostate cancer in their lifetime. In addition, the ACS estimates that by 2021, prostate cancer will cause more than 34,000 deaths with more than 248,000 new cases in the United States. According to the ACS, about 1 in 41 American men will die of prostate cancer. It is the second leading cause of cancer death in American men after lung cancer.

“Pathologists examine daily biopsies of tissue suspected of disease, such as prostate cancer. Identifying areas of concern in the biopsy image can help pathologists make a diagnosis that informs appropriate treatment, ”said Stenzel.

According to the FDA statement, the study used data from 16 pathologists reviewing 527 scanned prostate biopsy slide images that were scanned. Of the slides, 356 were benign and 171 were cancerous. Each of the slides was evaluated twice by pathologists, once with the help of Paige Prostate and once without.

The clinical study submitted to the FDA showed that pathologists using Paige Prostate increased performance by more than seven percentage points in accuracy, from 89.5% to 96.8% for cancer detection. In addition, the clinical study showed that non-specialist pathologists were as precise as prostate specialists who did not use the software.

With this new FDA approval, AI-based software is making significant progress in shaping the future of assistive tools for disease detection.

Copyright © 2021 Cami Rosso All rights reserved.

Source link

]]> 0
Pharmacists Can Play a Critical Role in Improving Healthcare Delivery in India, Health News, ET HealthWorld Sat, 25 Sep 2021 08:00:00 +0000 By Nikkhil K Masurkar

Pharmacists are the 3rd largest group of healthcare professionals in the world. A majority of pharmacists in India are involved in community settings which serve as the initial level of contact between individuals in a community and healthcare. With an Indian pharmaceutical market expected to reach $ 21 billion by FY21, with a CAGR of 4.5% and drug sales registering significant growth over the past year, the role of pharmacists, which is content to dispense and distribute drugs and medical supplies, is expected to undergo a major change that will help fill the gaps in health care and contribute significantly to national health efforts. Even though pharmacists play a key role in improving care, it is unfortunate that the majority of patients find no difference between the grocer and the pharmacist. It is the need of the hour to make pharmacists an integral part of the health system to provide better health care.

How Pharmacists Can Improve Healthcare in India

The participation of pharmacists can play a vital role in the following areas of health care in the country:

Appropriate use of drugs

A pharmacist can give advice on the administration of medicines, give information on storage conditions and, if necessary, he can advise the patient. A pharmacist can be one of the essential members of healthcare delivery by guiding patients on the rational use of medicines by adhering to good pharmacy practices. Research has shown that when pharmacists explain medications to patients that are prescribed to them, it can dramatically increase patient knowledge about correct medication use by 56-90%.

Also, in India, nearly 70% of the population is deprived of essential medicines for various reasons including the unavailability of health professionals and inappropriate professional advice on the use of medicines. The current number of pharmacists in India can play an important role in improving access to medicines and their safe use.

Dietary advice

Community pharmacists can become an excellent source for ensuring adequate nutrition for patients by advising them on basic dietary needs, correcting unhealthy eating habits in children, suggesting a special diet for people with food allergies or diabetes. and participating in campaigns organized in rural areas to educate people on the need for a balanced and nutritious diet. Facts such as people who eat fish are less prone to stroke, symptoms of hyper vitaminosis can cause irregular menstrual cycle, nutraceuticals / dietary supplements can offer many health benefits and pharmacists can communicate this more to ensure better health.

Educate people about sexually transmitted diseases-AIDS

According to the latest government report (2019), India would have around 23.49 lakh of people living with HIV / AIDS (PLHIV) in 2019. The cost of antiretroviral therapy (ART) used to treat

HIV is quite expensive and beyond the reach of a large proportion of the population. Pharmacists can help prevent HIV / AIDS by raising awareness and providing information such as what HIV is, its transmission, risk factors, prevention methods, etc.

Personalization of pharmacotherapy

The personalization of drug therapy described as the personalization of drug selection and drug dosage for a given patient is one of the biggest trends in medicine today. When a physician is concerned with the patient’s diagnosis, he or she is not able to devote time to counseling the patient regarding drug information, pharmaco-economics and alternative therapies, moral support, etc. ., a pharmacist can provide advice to the patient. It can store details of patient history, allergies and other details needed for treatment so that the concept of drug therapy individualization can be implemented.

What needs to be done to increase pharmacist participation in health care

With a severe shortage of healthcare professionals and a lack of properly trained providers in India, maximizing the knowledge and skills of pharmacists can help fill gaps in healthcare and provide a platform for different levels of professional development. .

While in most cases it has been observed that pharmacists have the technical skills but often lack the basic knowledge necessary to make the most of their skills as health practitioners. Those who pursue their careers in pharmacy need to be trained in basic public health skills to effectively manage community health, the essential elements of program planning, implementation, monitoring and evaluation.

With advancements in technology and innovation, implementation science is used to understand how to translate evidence into daily practice so that it can be used in all issues of public health, safety and security. drugs to mHealth. Implementation research can help provide the data needed by government to support the integration of pharmacists into public health services. be people across the country in resource-constrained settings.

In addition, there is an immediate need for double-trained professionals in pharmacy and public health. Although a small number of faculties of pharmacy in India offer dual degree programs with PharmD / MPH options, but overall, pharmacy students are only exposed to public health concepts momentarily. A handful of courses are devoted solely to public health in pharmacy, and there are hardly any textbooks to emphasize the role of pharmacy in public health. As a result, there is an urgent need for schools of pharmacy to integrate public health and pharmacoepidemiology courses into their curriculum and to train pharmacists as future public health professionals.

Final words

In the context of Indian healthcare, there is an underutilization of the practice of pharmacy and community pharmacy. Pharmacists working in community pharmacies do not provide advice to patients in the usual situation. Government and healthcare organizations need to work closely with pharmacist associations and share common experiences and develop appropriate guidelines so that the role of the pharmacist in providing better healthcare can be recognized.

By Nikkhil K Masurkar, Executive Director, ENTOD Pharma

(DISCLAIMER: Opinions expressed are solely those of the author and does not necessarily endorse them. will not be liable for any damages caused to any person / organization directly or indirectly.)

Source link

]]> 0
Vets call for vaccination as canine flu cases increase Sat, 25 Sep 2021 04:32:00 +0000

LA QUINTA, Calif. (KESQ) – It’s flu season and not only are humans getting the flu shot, but our furry friends are also advised to protect them from canine flu.

Kathryn Carlson, owner of Village Park Animal Hospital, says dogs can get very sick with canine flu.

“It actually develops into pneumonia,” she said.

Pneumonia can go unnoticed and eventually land a dog in the emergency room.

Los Angeles Veterinary Public Health recently reported its largest canine flu outbreak with 10 cases.

Because of this, Coachella Valley vets are seeing more and more people getting their dogs vaccinated against the flu.

“The most important thing to know is that there is a vaccine that prevents it,” Carlson said.

In recent weeks, the Village Park Animal Hospital in La Quinta, Calif., Said it has already detected three cases.

The canine flu test typically costs around $ 200, but Carlson says it’s important to detect when a dog has the flu.

“It’s really more serious as we start to see these outbreaks because you can certainly think of it as something minor like kennel cough and it can be something much more complicated,” he said. she declared.

If your dog is not yet immune to the flu, it is advisable to keep your pet out of certain situations.

“One of the ways they get this flu or any other kennel cough situation is in situations like dog parks or boarding houses, grooming facilities,” Carlson said. “You have to be very careful where you take your dog these days.”

If your dog does get the flu, he needs to be isolated from other dogs to prevent the spread.

“They should be quarantined if your dog was with another dog who had the flu,” Carlson said.

Copyright 2021 KESQ via CNN Newsource. All rights reserved.

]]> 0
Always number one somewhere – The Chronicle Sat, 25 Sep 2021 04:00:00 +0000

Last week, the 2022 National Top Universities edition of US News was released. Fortunately, Duke has emerged from the abyss of double digits to a comfortable # 9. Our fragile egos are at rest.

There is one statistic, however, where Duke still remains number one: the percentage of undergraduate women who report some kind of sexual assault during their four years at Duke. In this category, we systematically distinguish ourselves from peer institutions. At Harvard, 33% of female undergraduates report having engaged in some kind of unwanted sexual conduct in their four years on campus. At Yale, that number was 39%. Data collected from a number of other schools tells a similar story:

● Pennsylvania: 33%

● Stanford: 39%

● Cornell: 27%

● Northwest: 31%

● Brown: 25%

● Vanderbilt: 27%

● University of Michigan: 34%

● And, of course, the University of North Carolina at Chapel Hill: 35%.

Duke? 48%. *

These numbers are incredibly high. On average, more than three in ten women in these schools report sexual assault. These data highlight a larger problem in American society: the lack of control for those at the top. We hold these institutions in high esteem. This is where CEOs and politicians send their children. Time and time again we are told that they are incubators for the brightest minds of tomorrow. Yet these numbers suggest that no matter how hard they try to climb the ranks of society, women cannot expect their own safety. Our university – and every like it – is spawning a new generation of film producers, actors, TV presenters, politicians, and executives who feel empowered to have the bodies of others. How can it happen that “Time’s Up” has passed when so few women have the time of day?

This leads us to an even more uncomfortable conversation: As terrible as these institutions are for women and center women, Duke is distinguished by his horror. There are no definitive answers as to why. This is likely due in part, as previous Chronicle authors have suggested, to Duke’s relatively weak sexual assault prevention training program. Part can be attributed to the prevalence of Greek life. But a lack of access to information is unlikely to be the root of the sexual assault in a place like Duke. In this case, it seems unfair to attribute to ignorance what can be more aptly described as malice. And likewise, Greek schools, like Vanderbilt and Northwestern, have much lower rates of sexual assault than we do. It’s time for us to embrace a difficult truth: that Duke’s women suffer just because no one cares enough to do anything about it. The administration is content with complacency, probably in part because the university’s rankings keep rising despite their inaction. And maybe students have known about this 48% statistic for so long that we started to take it for granted. This is my biggest fear: that once we forget how abnormal our treatment of women is, the less likely we are to change it.

So far, I have also failed to mention the plight of other minority groups facing high rates of sexual violence. The Association of American Universities (AAU) Campus Climate Report, which released statistics on female sexual assault from other schools, distinguishes TGQN students (transgender, genderqueer / non-binary, gender questioning, or gender not listed) as particularly at risk. While Duke does not have specific data on these identities, their statistics on gay, lesbian and bisexual college students (50% of GLB women and 28% of GLB men) suggest that the issues plaguing our campus do not only affect students. cisgender heterosexual women. The AAU data is not comprehensive enough to draw conclusions about Duke’s sexual assault statistics for students and men with disabilities compared to other schools. Yet their suffering – 13% of men, 56% of women with disabilities and 23% of men with disabilities – should not be forgotten just because it cannot be brought to light next to the Ivy Leagues.

Where do we go from here? As with so many things in the world, the responsibility for reform rests primarily with men. I’m sure almost every woman in Duke knows this 48% statistic by heart. But I don’t know how many men do it. Duke’s men need to be better allies, not just performative social media activists. They can be better listeners and more observant gatekeepers. They can share the security that their gender identity gives them with those around them. I will be highlighting the Duke Men’s Project, a learning community sponsored by the Women’s Center that provides a space for middle men to learn and reflect on their own identity. If we collectively take the time to consider the impacts of our actions, large and small, we can create safer and happier communities.

48, not 9, is the number Duke’s students should scroll around campus until he muffles the noise of anything else. After all, I don’t see any statistics on sexual assault counted in US News or any other college ranking system, even though those numbers will affect students’ college experiences. far more than statistics like the faculty to student ratio ever would. 48 is the number we should repeat until it is no longer such a distinctive feature of our university as our athleticism or our architecture. Because the longer we wait, the more we brainwash ourselves into thinking that we can’t change and the more Duke’s women will have to suffer thinking that their pain is just a fact of life.

* Duke did not participate in the 2019 AAU survey, which is where the data for the other schools on this list comes from. This explains the lack of comparable data on students with disabilities and TGQN. There may also be slight differences in the methodology or implementation of the survey. You can read more about Duke’s decision here.

** Thanks to Lily Levin, whose previous article “Forty-Eight Percent” influenced my writing.

James Gao is a second year student at Trinity. His columns are broadcast alternately on Fridays.

Source link

]]> 0
Two Argonne scientists receive DOE funding for quantum research Fri, 24 Sep 2021 20:25:00 +0000

Newswise – David Awschalom and Oleg Poluektov from Argonne study the materials and chemical processes needed to develop the next generation of quantum smart devices and quantum computing technology.

The US Department of Energy (DOE) awarded funding to two scientists from its national laboratory in Argonne to advance research in quantum information science: David Awschalom and Oleg Poluektov.

The DOE awards support the development of intelligent quantum devices and quantum computing technology, next-generation tools capable of solving today’s most pressing challenges, especially in national security, the development of new materials and logistics.

Quantum science represents the next technological revolution and the next frontier in the information age, and America is at the forefront, ”said US Secretary of Energy Jennifer M. Granholm. TO DOE, we are investing in basic research, led by universities and our national laboratories, that will improve our resilience in the face of growing cyber threats and climate disasters, paving the way for a cleaner and safer future.

Awschalom, a senior scientist from Argonne, received the award for advancing the science needed to develop a metropolitan scale quantum information network – analogous to the Internet – without the need for quantum repeater technologies. Quantum repeaters retransmit a signal that would otherwise fade before reaching its destination in a quantum network.

Using a three-node fiber network at Chicagoland as a test bed for quantum information transfer, Awschalom’s project is to develop repeaterless quantum network technologies and protocols under real-world conditions, including multi-node quantum networking, the synchronization of different types of quantum nodes, and the distribution of quantum entanglement (a property of subatomic particles).

Metro-scale repeaterless technology and the development of fiber network protocols complement chip-scale quantum technologies and repeater protocols developed within Q-NEXT, a DOE National Center for Research in Quantum Information Sciences headed by Argonne.

I am delighted to receive this award, which allows us to explore the science behind future game-changing quantum communication technologies, ”said Awschalom, who is also the director of Q-NEXT; University of Chicago Professor Liew Family in Molecular and Physical Engineering and Pritzker School of Molecular Engineering Associate Dean for Research and Infrastructure; and the director of the Chicago Quantum Exchange.We are on the cusp of a revolution in quantum science, and the discoveries we make here will have far-reaching impacts, leading to breakthroughs in fields as diverse as finance and medicine – and even beyond. of what we can imagine. ”

Argonne’s lead chemist, Oleg Poluektov, received his award for understanding how quantum effects influence solar energy conversion processes in nature. The study focuses on the effects of coherence, which refers to the duration and strength of persistence of a particular quantum state.

Scientists know that certain types of coherence – electronic and vibronic – are involved in the transport of light energy in photosynthetic proteins, which help convert light into energy. Poluektov is now investigating whether a third type, spin coherence, is also involved.

Spin is a property of all subatomic particles, including electrons. The spins of two electrons can become entangled – inseparably correlated. The longer the spins maintain their entangled state, the greater their spin coherence. Rotational entanglement is a key factor in birds’ inner compasses, allowing them to navigate the world. Could this be a factor in photosynthetic processes?

Poluektov will study how spin coherence contributes to the efficiency of photosynthetic conversion of solar energy. He will also identify the mechanisms that nature uses to preserve the entanglement of spins in photosynthesis.

I am grateful to have been chosen for this award, ”said Poluektov.We hope that the results of this work will contribute to the design of future artificial solar energy conversion systems. This is an example of how a better understanding of the quantum domain could have profound impacts on energy conservation.

The DOE quantum information science research award totals $73 million and will be distributed to 29 recipients.

This work is supported by the DOEScience office.

Argonne National Laboratory seeks solutions to urgent national problems in science and technology. The country’s leading national laboratory, Argonne conducts cutting-edge fundamental and applied scientific research in virtually all scientific disciplines. Argonne researchers work closely with researchers from hundreds of companies, universities, and federal, state, and municipal agencies to help them solve their specific problems, advance U.S. scientific leadership, and prepare the nation for a better future. With employees over 60 nations, Argonne is managed by UChicago Argonne, SARL for the United States Department of Energy Science Office.

The Office of Science of the United States Department of Energy is the largest proponent of basic physical science research in the United States and strives to address some of the most pressing challenges of our time. For more information visit https: // ener gy .gov / s c ience.

Source link

]]> 0
Respected Veterinarian and Technical Expert Dr Edgar Diaz Joins Swine Team | Your money Fri, 24 Sep 2021 19:18:18 +0000

LENEXA, Kan. – (BUSINESS WIRE) – Sep 24, 2021–

Edgar Diaz, accomplished scientist, academic, veterinarian and animal health business leader, has joined Ceva Animal Health as Director of Swine Technical Services. In his new role, Dr Diaz will focus on continuing to grow the company’s personalized swine vaccines, developing the genomic platform, and supporting the sales team to provide tailored solutions to veterinarians and pig producers.

This press release features multimedia. View the full release here:

Dr Edgar Diaz, respected veterinarian and technical expert, joins Ceva Animal Health as Head of Pigs Technical Services. (Photo: Business Wire)

“We are very proud to welcome Dr. Diaz to the team,” said Gary Robertson, Head of the Hog Business Unit. “As a well-respected veterinarian, dedicated leader and proven executive, Dr. Diaz possesses a unique combination of skills and perspectives. With over 30 years of experience in swine medicine, his knowledge increases our vast expertise in the management of swine diseases. His extensive experience in research and as a practitioner will provide incredibly valuable information as we continue our growth and leadership in animal health. “

Dr Diaz most recently served as Director of Marketing at Newport Laboratories for Boehringer Ingelheim Animal Health, and he was also President of Newport Laboratories from 2017 to 2019. He has also served as Commercial Director and held several technical service positions at during the course of his career in the United States, Spain and Mexico.

Dr Diaz received his doctorate in veterinary medicine and zootechnics from the National Autonomous University of Mexico in 1989, where he also taught pathology, clinical pork diagnostics and immunology. He is the author of over 200 technical papers, articles and research bulletins on a wide variety of swine diseases and health issues around the world.

“Ceva has an excellent reputation for innovation and customer service in the animal health industry, and I am honored to be a part of it,” said Dr Diaz. “I look forward to working closely with Gary and the sales team to amplify the impact of our company’s remarkable capabilities for veterinarians and producers. “

For more information about Ceva Swine or for career opportunities, visit

About Ceva Santé Animale:

Ceva Animal Health offers a growing line of products to meet the health needs of companion animals, poultry and pigs. Ceva established its presence in the United States in 2005. Since then, the company has invested nearly $ 100 million in facilities supporting the growth of research and development as well as vaccine production. Ceva currently supplies more than 70 countries with essential vaccines from the company’s North American headquarters in Lenexa, Kansas. To find out more, visit

See the source version on

CONTACT: Jody Donohue, ARP, SCMP

Communication manager

Ceva Animal Health

Office: (913) 945-4405

Mobile: (913) 333-6329




SOURCE: Ceva Animal Health, LLC

Copyright Business Wire 2021.

PUB: 24/09/2021 15:18 / DISC: 24/09/2021 15:18

Copyright Business Wire 2021.

]]> 0
Virtual awards ceremony gives recognition to outstanding faculty Fri, 24 Sep 2021 16:20:25 +0000

Friday, September 24, 2021

A long-standing tradition of Purdue University College of Veterinary Medicine of recognizing outstanding faculty at the annual conference Purdue Veterinary Conference continued in a virtual format in 2021. The annual September 10 awards ceremony included the presentation of the prestigious Raymond E. Plue Award for Outstanding Teacher as well as several other awards for faculty service, research and education. ‘education.

The Raymond E. Plue Outstanding Teacher Award is funded by an endowment established by Dr. Plue, a member of the DVM class of 1968, to recognize faculty members for their teaching ability as well as their role in fostering interest in research. To be considered for this honor, a faculty member must be nominated by veterinary alumni in the last five promotions. The 2021 recipient is Dr Darryl Ragland, Associate Professor of Food Animal Production Medicine in the Department of Veterinary Clinical Sciences and Head of the Production Medicine Section at Purdue University Veterinary Hospital.

Dr Ragland received his DMV from Tuskegee University before coming to Purdue for a residency in food animal medicine and surgery. After earning his doctorate, Dr. Ragland joined the Purdue School of Veterinary Medicine in 1999 as an Assistant Professor.

Dr. Ragland divides his time between clinical practice, teaching and research. Much of his research focuses on swine nutrition, although he recently published a study titled “Assessment of Biosecurity Policies and Practices for the Control of African Swine Fever Virus in Ukrainian Pig Farms”. To date, Dr. Ragland’s research has been published in 52 peer-reviewed publications.

Dr Ragland also has multiple teaching responsibilities at the college, including teaching medicine and nutrition in pig production to DVM students. In addition, Dr. Ragland has recently been heavily involved in the creation of a new food animal medicine course for which he is now a regular instructor. He also played a major role in the college’s breeding classes, working with Professor Emeritus Michael Hill. Additionally, Dr. Ragland has served as an academic advisor to 38 DVM students and served on graduate committees for over 30 graduate students.

In addition to the Plue Award, eight other faculty awards were presented during the Virtual Awards program. The awards recognized exceptional teaching, research and commitment. The awards and recipients are:

Dr. John Christian, Associate Professor of Veterinary Clinical Pathology in the Department of Comparative Pathobiology, and Section Director and Head of the Clinical Pathology Laboratory, received the Outstanding Alumni Teaching Award.

Alumni Faculty Excellence Award | Dr Ann Weil, Clinical Professor of Anesthesiology in the Department of Veterinary Clinical Sciences and Head of the Anesthesiology Section at Purdue University Veterinary Hospital

Nominations for this award are submitted by faculty and selection is made by a committee of faculty and alumni based on the candidate’s performance and contributions in research, academic or creative endeavors; instruction and related activities; and / or public and professional services and relations.

Zoetis Distinguished Teacher Award | Dr Kevin Hannon, Associate Professor of Basic Medical Sciences

This award is one of two selected based on an annual vote completed by Purdue veterinary students indicating the degree to which faculty members demonstrate superior ability to communicate selected material to students and stimulate their desire to master material, while being ready to help and motivate students as advice and guidance, formally or informally. The Zoetis Distinguished Teacher Award is presented annually to an outstanding teacher in every veterinary school in North America. Each award recipient is also eligible to compete for the national Zoetis Distinguished Teacher Award.

Marxa is pictured with her award plaque standing next to the Continuum sculpture in front of Lynn Hall
Dr. Marxa Figuiredo, Associate Professor of Basic Medical Sciences, received the 2021 Research Excellence Award.

Outstanding Alumni Teaching Award | Dr John Christian, Associate Professor of Veterinary Clinical Pathology and Director and Head of Section of Clinical Pathology Laboratory

This award is also selected on the basis of student vote and recognizes the recipient’s role in student success.

Excellence in Teaching Award | Dr Andrew Woolcock, Associate Professor of Small Animal Internal Medicine in the Department of Veterinary Clinical Sciences

The recipient of this award is chosen from nominations made by peers. The award includes $ 3,000 in funds to support university teaching activities.

Zoetis Prize for Excellence in Veterinary Research | Dr Maggie O’Haire, Associate Professor of Human-Animal Interaction at the Department of Comparative Pathobiology

This award recognizes faculty members for their role in generating new knowledge through basic and clinical research.

Excellence in Research Award | Dr Marxa Figueiredo, Associate Professor of Basic Medical Sciences in the Department of Basic Medical Sciences

Rebecca smiles while holding her award plaque outside the diagnostic lab
Dr. Rebecca Wilkes, Associate Professor of Molecular Diagnostics in the Department of Comparative Pathobiology and Head of the Molecular and Virology Sections of the Animal Disease Diagnostic Laboratory, received the 2021 Service Excellence Award.

This award for outstanding basic and clinical research is sponsored by the College of Veterinary Medicine.

Service Excellence Award | Dr Rebecca Wilkes, Associate Professor of Molecular Diagnosis in the Department of Comparative Pathobiology and Head of the Molecular and Virology Sections at the Animal Disease Diagnostic Laboratory

Created to honor the Purdue School of Veterinary Medicine which has demonstrated consistent and sustained service delivery in our college, this award was presented to recognize Dr. Wilkes as a national leader in molecular diagnostics and for his pivotal role in success of the Animal Disease Diagnostic Laboratory in supporting the Protect Purdue initiative by testing human samples for COVID-19.

Faculty Excellence Award for Diversity and Inclusion | Dr Susan Mendrysa, Associate Professor of Basic Medical Sciences in the Department of Basic Medical Sciences

This award honors faculty at the College of Veterinary Medicine who demonstrate a commitment to diversity and inclusion through active recruitment and retention efforts, teaching, research, multicultural programming, outreach activities community or other initiatives.

Congratulations to all the winners! Click here to view the award ceremony on PVM’s YouTube channel.

Susan Xioufaridou and Kevin Doerr |

Source link

]]> 0
Susan H. Lee retires from St. Luke’s Episcopal Church in Fall River Fri, 24 Sep 2021 14:15:35 +0000

FALL RIVER – In honor of Reverend Susan H. Lee’s retirement, a service of the Holy Eucharist will be held at 9:30 am on Sunday, September 26 at St. Luke’s Episcopal Church, 315 Warren Street. , Autumn river.

The public is invited to attend the service and reception that will follow. There will be overflow seats in the gymnasium to allow for social distancing, and masks are required.

Lee received his bachelor’s degree from Brown University and earned a master’s degree in divinity from Harvard Divinity School. She was ordained a deacon in Providence, Rhode Island, in June 1988 and began her ministry in St. Luke’s on July 1, 1988. The Rt. Reverend George Hunt ordained her to the priesthood on March 4, 1989, at the time of a church liturgy. Lee was the first ordained woman in the town of Fall River, and the service received extensive press coverage. She was Associate Rector and Co-Rector with Reverend James Hornsby for 14 years before becoming Rector in 2002.